Julian Hiscox

28PUBLICATIONS
129CO-AUTHORS
Molecular targetsEpidemiological modellingMajor global burdens of diseasePharmaceutical delivery technologiesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 07, 2026
Identifying molecular signatures underpinning treatment responses to novel therapeutics influencing COVID-19 outcomes.

|Jun 17, 2026
Identification of host gene transcripts by machine learning and their application to predict outcome in Ebola virus disease.

|Jun 17, 2026
Molecular phenotypes of sex and age specific differences relating to outcome in patients with Ebola virus disease.

|Mar 18, 2026
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.

Tim Rowland, Richard FitzGerald, Elizabeth Challenger

|Nov 11, 2025
Discontinuous EBOV RNA synthesis events in patients with Ebola virus disease and their relationship to viral load and outcome of infection.

Xiaofeng Dong, Isabel Garcia-Dorival, Natasha Y Rickett

|Jun 04, 2025
SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management.

Dung Nguyen, Stephen M Laidlaw, Xiaofeng Dong

Pageof 5

Frequent Collaborators

8 joint publications

Rebekah Penrice-Randal

5 joint publications

Andrew Owen

5 joint publications

James P Stewart

4 joint publications

Miles W Carroll